Local Coverage Determination (LCD)

Blood Glucose Monitoring in a Skilled Nursing Facility (SNF)

L34834

Expand All | Collapse All
Proposed LCD
Proposed LCDs are works in progress that are available on the Medicare Coverage Database site for public review. Proposed LCDs are not necessarily a reflection of the current policies or practices of the contractor.

Document Note

Note History

Contractor Information

LCD Information

Document Information

Source LCD ID
N/A
LCD ID
L34834
Original ICD-9 LCD ID
Not Applicable
LCD Title
Blood Glucose Monitoring in a Skilled Nursing Facility (SNF)
Proposed LCD in Comment Period
N/A
Source Proposed LCD
N/A
Original Effective Date
For services performed on or after 10/01/2015
Revision Effective Date
For services performed on or after 11/07/2019
Revision Ending Date
N/A
Retirement Date
N/A
Notice Period Start Date
N/A
Notice Period End Date
N/A

CPT codes, descriptions, and other data only are copyright 2023 American Medical Association. All Rights Reserved. Applicable FARS/HHSARS apply.

Fee schedules, relative value units, conversion factors and/or related components are not assigned by the AMA, are not part of CPT, and the AMA is not recommending their use. The AMA does not directly or indirectly practice medicine or dispense medical services. The AMA assumes no liability for data contained or not contained herein.

Current Dental Terminology © 2023 American Dental Association. All rights reserved.

Copyright © 2024, the American Hospital Association, Chicago, Illinois. Reproduced with permission. No portion of the AHA copyrighted materials contained within this publication may be copied without the express written consent of the AHA. AHA copyrighted materials including the UB‐04 codes and descriptions may not be removed, copied, or utilized within any software, product, service, solution, or derivative work without the written consent of the AHA. If an entity wishes to utilize any AHA materials, please contact the AHA at 312‐893‐6816.

Making copies or utilizing the content of the UB‐04 Manual, including the codes and/or descriptions, for internal purposes, resale and/or to be used in any product or publication; creating any modified or derivative work of the UB‐04 Manual and/or codes and descriptions; and/or making any commercial use of UB‐04 Manual or any portion thereof, including the codes and/or descriptions, is only authorized with an express license from the American Hospital Association. The American Hospital Association (the "AHA") has not reviewed, and is not responsible for, the completeness or accuracy of any information contained in this material, nor was the AHA or any of its affiliates, involved in the preparation of this material, or the analysis of information provided in the material. The views and/or positions presented in the material do not necessarily represent the views of the AHA. CMS and its products and services are not endorsed by the AHA or any of its affiliates.

Issue

Issue Description
Issue - Explanation of Change Between Proposed LCD and Final LCD

CMS National Coverage Policy

This LCD supplements but does not replace, modify or supersede existing Medicare applicable National Coverage Determinations (NCDs) or payment policy rules and regulations for blood glucose monitoring in a skilled nursing facility. Federal statute and subsequent Medicare regulations regarding provision and payment for medical services are lengthy. They are not repeated in this LCD. Neither Medicare payment policy rules nor this LCD replace, modify or supersede applicable state statutes regarding medical practice or other health practice professions acts, definitions and/or scopes of practice. All providers who report services for Medicare payment must fully understand and follow all existing laws, regulations and rules for Medicare payment for blood glucose monitoring in a skilled nursing facility and must properly submit only valid claims for them. Please review and understand them and apply the medical necessity provisions in the policy within the context of the manual rules. Relevant CMS manual instructions and policies may be found in the following Internet-Only Manuals (IOMs) published on the CMS Web site:


IOM Citations:

  • CMS IOM Publication 100-02, Medicare Benefit Policy Manual, Chapter 15, Sections 80.1, Clinical Laboratory Services, 80.6, Requirements for Ordering and Following Orders for Diagnostic Tests.
  • CMS IOM Publication 100-03, Medicare National Coverage Determinations Manual, Chapter 1, Part 3, Section 190.20 Blood Glucose Testing.
  • CMS IOM Publication 100-04, Medicare Claims Processing Manual, Chapter 7, Section 90.1 Glucose Monitoring.
  • CMS IOM 100-08, Medicare Program Integrity Manual, Chapter 13, Section 13.5.4 Reasonable and Necessary Provision in an LCD.


Change Requests References:

  • CMS Transmittal 80, Change Request 5743 of January 11, 2008


Social Security Act (Title XVIII) Standard References:

  • Title XVIII of the Social Security Act, Section 1861(h) Extended Care Services.
  • Title XVIII of the Social Security Act, Section 1862(a)(1)(A) states that no Medicare payment shall be made for items or services which are not reasonable and necessary for the diagnosis or treatment of illness or injury.
  • Title XVIII of the Social Security Act, Section 1862(a)(7). This section excludes routine physical examinations.
  • Title XVIII of the Social Security Act, Section 1833(e) states that no payment shall be made to any provider for any claim that lacks the necessary information to process the claim.

Federal Register References:

  • Title 42 Code of Federal Regulations (CFR) Chapter IV Subchapter B Part 410 Section 410.32(a) Ordering diagnostic tests.
  • Title 42 Code of Federal Regulations (CFR) Chapter IV Subchapter B Part 410 Section 410.18 Diabetes screening tests.
  • Title 42 CFR Chapter IV Subchapter B Part 411 Section 411.15 Particular services excluded from coverage.

Coverage Guidance

Coverage Indications, Limitations, and/or Medical Necessity

Notice: It is not appropriate to bill Medicare for services that are not covered (as described by this entire LCD) as if they are covered. When billing for non-covered services, use the appropriate modifier.

Compliance with the provisions in this policy may be monitored and addressed through post payment data analysis and subsequent medical review audits.

History/Background and/or General Information

Routine glucose monitoring of diabetics is never covered in a SNF. Please refer to the CMS manuals listed under the IOM Citations and the Federal Register sections above for complete coverage information related to blood glucose monitoring and glucose monitoring in a SNF.

Medicare pays for a blood glucose test only when the service meets all of the conditions of payment for a test payable under the clinical laboratory fee schedule including that the test must be ordered by the physician who is treating the beneficiary and the physician must use the results in the management of the beneficiary’s specific medical condition.

For payment to be made for a blood glucose test under Medicare Part B, a physician must certify that each test is medically necessary. A standing order for many tests over a time period is not sufficient documentation.

Repeated performance of finger-stick blood glucose tests to maintain standing orders for insulin injection or oral hypoglycemic agents does not meet the criteria for Part B payment in a SNF. Payment for nursing care glucose monitoring is encompassed under Medicare Part A and other payment methods. If the patient is in a skilled nursing facility, routine glucose monitoring (including any tests which are not promptly reported) is a part of routine personal care and is not a separately billed procedure (PM AB-00-108, December 2000).


The home glucose monitoring device is on the list of instruments that can be administered by providers registered under the Clinical Laboratory Improvement Amendments of 1988 (CLIA), including providers registered with only a certificate of waiver. However, Medicare Part B may only pay for a glucose monitoring device and related disposable supplies under the durable medical equipment benefit if the equipment is used in the home or in an institution that is used as a home. A hospital or SNF is not considered a home under the SSA, Sect. 1861 (h).


Blood glucose values are often necessary for the management of patients with diabetes mellitus, where hyperglycemia and hypoglycemia are often present. Please refer to CMS IOM Publication 100-03, Medicare National Coverage Determinations Manual, Chapter 1, Part 3, Section 190.20 for guidelines on blood glucose monitoring for the management of patients with diabetes mellitus.

The frequency of monitoring of blood glucose values should be determined by the physician on an individual basis while considering and documenting any of the following factors that affect glycemic control:

  • Variations and degree of glycemic control as documented by hemoglobin A1C levels
  • Treatment with insulin versus oral agents
  • Frequency of symptoms of hypoglycemia
  • Frequency of prior adjustments in therapy
  • Motivation/ability for self-care and the presence of limitations such as language barriers and mental illness
  • Presence of diabetic complications


Patients who have exhibited long-term control of blood glucose levels as evidenced by normal (per reference laboratory range) or steady A1C levels over a 6 month period, minimal or no changes in diabetic therapy, OR no complications of diabetes mellitus (to include retinopathy, neuropathy, or diabetic renal or vascular complications) do not require frequent blood glucose monitoring.


Implicitly, the laboratory result must be reported to the physician promptly in order for the physician to use the result and instruct continuation or modification of patient care; this includes the physician's order for another laboratory service. Compliance program guidance for laboratory services sets forth conditions under which a physician's order for a repeat laboratory service can qualify as an order for another covered laboratory service. A standing order is not usually acceptable documentation for a covered laboratory service.

Any laboratory study ordered on a continuing basis without a cutoff time frame and without documentation in the medical record supporting that any previously ordered study was evaluated, will be considered a standing order and therefore, not reimbursable. Examples of acceptable time frames are as follows: daily times 3 days, BID times 2 days, weekly FBS times 2 weeks.

It should be noted that this policy does not prohibit a nursing home's Medical Director from authorizing services or procedures in emergency situations in a manner consistent with the Medical Director's obligations under state or federal law. In such instances; however, there must be documentation as to why the circumstances warrant intervention into the attending physician's role of caring for the patient.

As stated above, for a laboratory test to be covered, the result must be reported to the physician promptly in order for the physician to use the result and instruct continuation or modification of patient care. The following are time frames for use in reporting the results of blood glucose testing “promptly” to the physician.

Reporting Abnormal Blood Glucose Results

When reporting the abnormal values listed below, the time frame in which the blood glucose result must be reported to the physician is dictated by that result.

When blood glucose values are 60-90 mg/dl (low) or 160-299 mg/dl (high), the physician must be notified of the results within 12 hours.

When blood glucose values are below 60 mg/dl (low) or over 300 mg/dl (high), the physician must be notified of the results immediately.

The above timeframes are appropriate for most patients. Depending on patient history and circumstances, shorter time frames may be clinically warranted.

When reporting an abnormal blood glucose value to the physician, the previous two or more results, as appropriate, should also be provided for trending purposes.

Reporting Blood Glucose Results within Normal Limits

In the absence of abnormal blood glucose results, the condition of the patient dictates the time frame for physician notification. The physician should be provided with a trending report consisting of the appropriate number of blood glucose values based on the frequency of monitoring.

Patient Category Timeframes for reporting to physician

Category A:

Blood glucose results must be reported to the physician within 12 hours for patients who have documented:

  1. Unstable diabetes mellitus with or without unstable glucose levels and are at risk for alterations in glucose levels, OR
  2. Fingerstick glucose monitoring performed at least two (2) times per day.


Category B:

Blood glucose results must be reported to the physician within 24 hours for patients who have documented:

  1. Diabetes mellitus which is not completely stable and are at some risk for alterations in glucose levels, although with less probability and/or lower magnitude of fluctuations, OR
  2. Fingerstick glucose monitoring performed less than two (2) times per day.


Effective January 1, 2005, the Medicare law expanded coverage to diabetic screening services. Some forms of blood glucose testing covered under this national coverage determination may be covered for screening purposes subject to specified frequencies. See 42 CFR 410.18 and section 90, chapter 18, of the Claims Processing Manual, for a full description of this screening benefit.

In addition, all other criteria for coverage as delineated in this LCD and Medicare regulations must be satisfied.

Limitations


Blood glucose measurements without prompt physician notification as outlined above are not covered as diagnostic laboratory tests.

The redetermination process may be utilized for consideration of services performed outside of the reasonable and necessary requirements in this LCD.

Summary of Evidence

N/A

Analysis of Evidence (Rationale for Determination)

N/A

Proposed Process Information

Synopsis of Changes
Changes Fields Changed
N/A
Associated Information
Sources of Information
Bibliography
Open Meetings
Meeting Date Meeting States Meeting Information
N/A
Contractor Advisory Committee (CAC) Meetings
Meeting Date Meeting States Meeting Information
N/A
MAC Meeting Information URLs
N/A
Proposed LCD Posting Date
Comment Period Start Date
Comment Period End Date
Reason for Proposed LCD
Requestor Information
This request was MAC initiated.
Requestor Name Requestor Letter
View Letter
N/A
Contact for Comments on Proposed LCD

Coding Information

Bill Type Codes

Code Description

Please accept the License to see the codes.

N/A

Revenue Codes

Code Description

Please accept the License to see the codes.

N/A

CPT/HCPCS Codes

Please accept the License to see the codes.

N/A

ICD-10-CM Codes that Support Medical Necessity

Group 1

Group 1 Paragraph:

N/A

Group 1 Codes:

N/A

N/A

ICD-10-CM Codes that DO NOT Support Medical Necessity

Group 1

Group 1 Paragraph:

N/A

Group 1 Codes:

N/A

N/A

Additional ICD-10 Information

General Information

Associated Information


Refer to the Local Coverage Article: Billing and Coding: Blood Glucose Monitoring in a Skilled Nursing Facility (SNF), A56591 for all coding information.

Documentation Requirements

  1. All documentation must be maintained in the patient’s medical record and made available to the contractor upon request.
  2. Every page of the record must be legible and include appropriate patient identification information (e.g., complete name, dates of service[s]). The documentation must include the legible signature of the physician or non-physician practitioner responsible for and providing the care to the patient.
  3. The submitted medical record should support the use of the selected ICD-10-CM code(s). The submitted CPT/HCPCS code should describe the service performed.
  4. Documentation must be evident in the patient's medical record to substantiate the medical necessity of the testing performed. The ordering physician should retain in the patient's medical record, history and physical examination notes documenting evaluation and management of one of the Medicare covered conditions/diagnoses, with relevant clinical signs/symptoms or abnormal laboratory test results, appropriate to one of the covered indications.
  5. Documentation must support that blood glucose monitoring was ordered by the physician and the laboratory result was reported to the physician promptly. The medical record must reflect the time the blood glucose result was obtained and the time the physician was notified. The documentation must also support that the results were used in the modification of care for the beneficiary's specific medical problem including changes/alterations in medications prescribed for the treatment of the patient's condition.


Appendices

N/A

Utilization Guidelines

In accordance with CMS Ruling 95-1 (V), utilization of these services should be consistent with locally acceptable standards of practice.

Sources of Information
Contractor is not responsible for the continued viability of websites listed.

Other Contractor Policies

Contractor Medical Directors

Original JL ICD-9 Source LCD L27475, Blood Glucose Monitoring in a Skilled Nursing Facility (SNF)
Bibliography

N/A

Revision History Information

Revision History Date Revision History Number Revision History Explanation Reasons for Change
11/07/2019 R4

LCD revised and published 11/7/2019 to completely remove the Coding Information Section from this LCD per CMS Change Request 10901. Please see the related Billing and Coding Article, A56591 for all codes and information related to coding and billing.

  • Other (CMS Change Request 10901)
06/13/2019 R3

LCD revised and published on 06/13/2019. The IOM Citations section was revised to add the section title to the CMS IOM Publication 100-02, Medicare Benefit Policy Manual, Chapter 15, Section 80.1 and 80.6 and to add the Reasonable and Necessary IOM reference since the language contained in that reference and the reference was removed from the body of the policy. References Title 42 Chapter IV Subchapter B Part 410.32(a) Ordering diagnostic tests, Title 42 Chapter IV Subchapter B Part 410 Section 410.18 Diabetes screening tests and Title 42 Chapter IV Subchapter B Part 411.15 Particular services excluded from coverage were added. LCD language that was from the IOM and or Federal Register has been removed and replaced with the applicable reference. All billing and coding related information, including the CPT and ICD-10 codes, has been moved to the Local Coverage Article: Blood Glucose Monitoring in a Skilled Nursing Facility (SNF) (A56591). There has been no change to coverage in this policy with this revision.

  • Other (Change in LCD process per CR 10901)
05/11/2017 R2 LCD revised and published on 05/11/2017 to add additional IOM references to the CMS National Coverage Policy section.
  • Other (Clarification)
10/01/2015 R1 LCD revised to create uniform LCD with other MAC jurisdiction .
  • Creation of Uniform LCDs With Other MAC Jurisdiction
N/A

Associated Documents

Attachments
N/A
Related National Coverage Documents
N/A
Public Versions
Updated On Effective Dates Status
11/01/2019 11/07/2019 - N/A Currently in Effect You are here
Some older versions have been archived. Please visit the MCD Archive Site to retrieve them.

Keywords

N/A

Read the LCD Disclaimer